Documents to download

The NHS in England spent £15.2 billion on medicines during the financial year 2015/16; a rise of over 20 percent since 2010/11. Currently, the cost of branded medicines is regulated primarily through a voluntary scheme; manufacturers/suppliers who do not join the voluntary scheme automatically join a statutory scheme. Unbranded, or generic medicines, are not regulated and rely on competition to keep prices down. Recent price increases of some generic medicines have led to concern that not enough is being done to regulate their price. In addition, income from the voluntary scheme has reduced and some manufacturers/suppliers have chosen to join the statutory scheme, which does not involve the same payments to the Government under the voluntary scheme.

The Bill includes provisions to bring the current statutory medicines pricing scheme, which applies to branded medicines, into line with the voluntary scheme: the Pharmaceutical Price Regulation Scheme (PPRS). The Bill would also allow the Secretary of State to make regulations to limit prices of, or profits relating to, unbranded medicines. Currently, the Government cannot apply price controls to the unbranded generic medicines of those companies who are members of the PPRS; the Bill would remove this loophole.  In addition, the Bill would introduce a new power regarding information provision, which would enable the Secretary of State to make regulations to obtain information about health service medicines and other supplies from all parts of the supply chain. The information would be used for defined purposes, set out in the Bill.

The Bill was broadly welcomed by Labour, the Scottish National Party and the Liberal Democrats. Several government amendments were made at committee stage and a new clause was added, relating to the information provision requirements in the Bill. A small number of government amendments were also made at report stage. No non-government amendments were successful at either committee or report stage. An amendment to ring fence the money collected through the voluntary scheme to invest in “access to new and innovative medicines and treatments”, was defeated on division at committee stage, as was another to specify reporting requirements that the Secretary of State should follow in assessing the impact of the Bill. This briefing provides an overview of the clauses of the Bill and details its passage through the House of Commons in advance of the Bill’s second reading in the House of Lords.


Documents to download

Related posts

  • Government review of physician and anaesthesia associates

    The government recently announced an independent review of physician and anaesthesia associates to be led by Professor Gillian Leng. This announcement followed a debate about the use of the roles in the NHS and concerns raised by some stakeholders about patient safety. The review has been widely welcomed by stakeholders as a way to move the debate forward.

    Government review of physician and anaesthesia associates
  • Fracture liaison services: Towards 100% coverage in England

    Fracture liaison services proactively identify people at risk of fractures caused by osteoporosis. Patients can then be assessed and treated to prevent future fractures. The provision of fracture liaison services in England has been called a ‘postcode lottery’ by the Royal Osteoporosis Society, and evidence shows variation in quality and reach. The government has committed to 100% coverage by 2030.   

    Fracture liaison services: Towards 100% coverage in England
  • Mental Health Bill [HL]: HL Bill 47 of 2024–25

    The Mental Health Bill [HL] is a government bill that would amend the Mental Health Act 1983. The 1983 act is the current legislation that regulates the compulsory detention and treatment of those with a mental disorder in England and Wales. There have long been calls to update the legislation, and in 2017 there was an independent review of the Mental Health Act. In 2022 the previous Conservative government published a draft Mental Health Bill. The current bill is similar (but not identical) to the draft bill and it would implement many of the recommendations of the 2017 independent review. Changes proposed in the bill include tightening the detention criteria in the 1983 act and providing for more frequents reviews; limiting the period that people with autism or a learning disability can be detained; and removing prisons and police stations as “places of safety” in the act. This briefing provides a summary of the background to the bill, the bill’s provisions, and the differences from the 2022 draft bill.

    Mental Health Bill [HL]: HL Bill 47 of 2024–25